FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmaceutics, namely to a method for increasing patient's consciousness level in the vegetative state. Method involves stimulating vasculogenesis and neurogenesis and increasing the degree of vascularisation of the involved cerebral tissue by the therapeutic course of the Cellex® preparation in a certain dose, subcutaneously in the skin fold area of the deltoid muscle daily for 15 days.
EFFECT: invention provides higher clinical effectiveness in cerebral lesions in vegetative patients, prevention of risk of complications in patients due to subcutaneous administration of the preparation, minimizing adverse reactions and avoiding undesirable phenomena.
1 cl, 7 tbl, 3 ex
Authors
Dates
2021-01-22—Published
2020-03-11—Filed